Loading...
OTCM
IMPZY
Market cap230mUSD
Oct 06, Last price  
0.08USD
Name

Implanet SA

Chart & performance

D1W1MN
OTCM:IMPZY chart
P/E
—
P/S
16.46
EPS
—
Div yield, %
1,245.93%
Shrs. gr., 5y
115.49%
Rev. gr., 5y
26.23%
Revenues
12m
+32.62%
6,646,7886,690,3827,038,4166,653,3747,825,0007,841,0006,720,0007,407,0003,892,0006,140,0008,028,0007,447,0009,406,00012,474,000
Net income
-4m
L+0.37%
-4,276,635-6,843,456-6,871,586-8,007,562-7,288,000-6,612,000-5,551,000-3,645,000-3,976,000-3,088,000-3,540,000-6,676,000-4,366,000-4,382,000
CFO
-589k
L-73.12%
-3,988,432-5,385,988-5,293,119-6,811,336-5,892,000-4,465,000-4,443,000-2,809,000-3,018,000-3,449,000-2,404,000-1,447,000-2,191,000-589,000
Dividend
Nov 17, 20250.000174 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Implanet S.A., along with its affiliated entities, focuses on the creation, production, and distribution of medical implants for both spinal and orthopedic applications. The firm's product range encompasses solutions for spinal conditions and knee replacements. Specifically, its spinal offerings feature a variety of posterior fixation systems, including the Jazz PF, Jazz Evo, Jazz Cap SP, Jazz Passer, Jazz Lock, Jazz Claw, Jazz Frame, and ISS-Jazz Screw. For knee patients, Implanet also supplies prosthetic devices under the Madison brand. The company maintains a significant strategic alliance with Shanghai Sanyou Medical Co, Ltd. Established in 2006, Implanet S.A. is based in Martillac, France.

Key people

David Dieumegard
Chief Financial Officer
Franck Laporte
Chief Operating Officer
Shane Doyle
Vice President US Sales and Marketing
Laurent Penisson
Director of Sales Out of US · since 2017
Nicolas Marin
Marketing Director
Ludovic Lastennet
Chief Executive Officer, Director · since 2013
Mary Shaughnessy
Independent Director
Paula Ness Speers
Independent Director
IPO date
Nov 25, 2013
Employees
42
Domiciled in
FR
Incorporated in
FR
Headquarters & legal address
ALL F MAGENDIE
TECHNOPOLE BORDEAUX MONTESQUIEU
MARTILLAC 33650
FR
Trading name
IMPLANET IMPLA- PARTNERS IMPLANET INSTIT

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT